Smarter GMP Compliance Starts With Annex
Smarter GMP Compliance Starts With Annex 1: What Every Indian Pharma Manufacturer Must Know Before Building If you are planning a sterile manufacturing facility or upgrading an existing pharma plant anywhere in India — whether in Ahmedabad , Mumbai , Hyderabad , or Bangalore — the revised Annex 1 of the EU GMP guideline is no longer just a European concern. It has become the global benchmark for sterile product manufacturing, and Indian regulators, especially under CDSCO and WHO-GMP frameworks, are increasingly aligning with its principles. Getting this foundation right from Day 1 is what separates a compliant plant from one that faces repeated audit failures and costly retrofits. At QxP Pharma Project & GMP Services , we see this play out regularly. A client in Surat once came to us after spending ₹3.8 crore on a cleanroom that failed WHO-GMP inspection because the HVAC zoning logic did not meet contamination control strategy (CCS) requirements — a central Annex 1 concept...